Follow the Lincoln Pharmaceuticals Limited share price and the full management transaction log of the company, a listed equity based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Lincoln Pharmaceuticals Limited has published 137 reports. Market capitalisation: €11.6bn. The latest transaction was disclosed on 6 June 2024 (Purchase). Among the most active insiders: Munjal Mahendrabhai Patel. The full history is openly available.
137
Insider Decl.
n/a
Thresholds
€15m
131 ops.
Buy Volume
€2m
6 ops.
Sell Volume
10Σ signal
Buys €15m€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,283 of 28,799 companies
75.9
score / 100
Value
73
Quality
79
FCF yld6.9%
Earn yld7.6%
EV/EBITDA8.9x
ROE12%
Gross mgn54%
Net mgn13%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.